powered by centersite dot net
Medications
Resources
Basic InformationLatest News
When Is an Opioid Safe to Take?Lifesaving Drugs From Pfizer in Short Supply: FDALeading U.S. Doctors' Group Takes Aim at Rising Drug PricesU.S. Hospitals Still Prescribe Too Many Antibiotics: StudyBirth Control Pills Recalled Due to Danger of Unintended PregnancyNew Drugs Show Promise as First to Prevent MigraineMedication Adherence Up With Refill Synchronization ModelModified Vancomycin May Help Fight Bacterial ResistanceScientists Tweak Antibiotic to Boost Power Against 'Superbugs'New Cholesterol Fighting Meds Target Key GeneResearchers Say PDE5 Inhibitors Don't Cause MelanomaNearly a Third of Drugs Hit by Safety Issues After FDA ApprovalU.S. Moves to Avert Shortage of Yellow Fever VaccineOpioid Use by Iraq, Afghanistan War Vets Mirrors Rest of U.S.: StudyApril 29 Is National Prescription Drug Take Back DayERs Administering More Medications IntranasallyFDA Warns Against Children Taking Codeine, TramadolPhysicians Finding Ways to Work Around Cost of Rx MedicationsRuling Out Penicillin Allergy by Testing Inpatients Saves MoneyEpiPen Out-of-Pocket Costs More Than Doubled Over DecadeAACR: Regular Aspirin Use Linked to Lower Cancer MortalityFDA Approves Noctiva Nasal Spray for Nocturnal PolyuriaFDA Approves Odactra for House Dust Mite AllergiesHow Much Melatonin Is Really in That Supplement?Antidepressant Efficacy Varies for Depressive Symptom ClustersDo You Need an Antibiotic?'Off-Label' Antidepressants Common, But Where's the Evidence?Docs More Likely to Prescribe Antibiotics If Patients Expect ThemSimilar Adverse Event Risk for Typical, Atypical AntipsychoticsRx Adherence Reminders No More Effective at 'Fresh Start' DatesThink You're Allergic to Penicillin? Check AgainExcessive FDA Regulation Driving High Drug PricesOutcomes-Based Pricing Suggested for New, Costly DrugsPrices Skyrocket on Drugs Widely Used by Seniors: Report1 in 6 U.S. Adults Takes a Psychiatric Drug: StudyU.S. Doctors Still Over-Prescribing Drugs: SurveyWider Low-Dose Aspirin Use Would Save U.S. $692 Billion: StudyHealth Tip: Get the Facts About AntibioticsThese Medicines Often Send Americans to ERsHealth Tip: Be Aware of Drug and Food InteractionsCan Time-Release Capsules Replace Daily Pills?Prices of Generic Heart Failure Drugs Vary WidelyAmericans Fed Up With Soaring Drug Prices: HealthDay/Harris PollSaturday, Oct. 22 Is Drug Take Back DayHow Older People Can Head Off Dangerous Drug InteractionsCDC: Too Many Antibiotics Still Being Prescribed in U.S.Codeine Not Safe for Kids, Pediatricians WarnHealth Tip: Reading the Label on OTC MedicationsMylan to Offer Generic EpiPenSteep Rise in U.S. Drug Prices Tied to Patent Monopolies
Questions and AnswersVideosLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Mental Disorders
Mental Health Professions

Scientists Tweak Antibiotic to Boost Power Against 'Superbugs'

HealthDay News
by -- Robert Preidt
Updated: May 30th 2017

new article illustration

TUESDAY, May 30, 2017 (HealthDay News) -- Health experts have long warned about the looming health threat posed by "superbug" bacteria that can mutate to resist antibiotics.

But now scientists say they've modified an existing antibiotic, vancomycin, to make it a much more potent fighter against these germs.

"Doctors could use this modified form of vancomycin without fear of resistance emerging," research leader Dale Boger of The Scripps Research Institute in La Jolla, Calif., said in an institute news release.

As Boger's team explained, vancomycin has been used for 60 years, but bacteria are now developing resistance to it. The drug works by disrupting how bacteria form their cellular walls.

Vancomycin is "magical" for its proven ability to fight infections, said Boger, who is co-chair of Scripps' department of chemistry.

Previously, he and his colleagues showed that two modifications to the antibiotic made it even more effective. In this new study, they made a third modification.

Together, the three modifications give vancomycin a 1,000-fold increase in activity, meaning it would require much less of the antibiotic to fight infection, the study authors said.

"This increases the durability of this antibiotic," Boger said. "Organisms just can't simultaneously work to find a way around three independent mechanisms of action. Even if they found a solution to one of those, the organisms would still be killed by the other two."

In laboratory tests, the new version of vancomycin killed both vancomycin-resistant Enterococci bacteria and the original forms of Enterococci, the findings showed.

The next phase of the research involves finding a quicker way to produce the modified vancomycin in the lab. The current method has 30 steps. But Boger said that shortening production should be "easy" compared to the process needed to develop the modified drug in the first place.

Dr. Bruce Farber is chief of infectious diseases at Long Island Jewish Medical Center in New Hyde Park, N.Y. He reviewed the new findings and noted that "vancomycin has been, and continues to be, a very important tool" in the fight against bacterial disease.

"It is still used extensively to treat MRSA [methicillin-resistant Staphylococcus aureus, a common superbug] and other organisms. It is amazing that it still is active after being used for so many years," he said.

Farber applauded the new research, and added that "anything that can improve its activity would be very helpful in the current era of highly resistant organisms."

Another medical expert agreed.

"Experts have become increasingly alarmed about the possibility of a 'post-antibiotics era' in which some infections, at least, would be impervious to all known medications," said Dr. Michael Grosso, medical director of Huntington Hospital in Huntington, N.Y.

"The goal of researchers and the pharmaceutical industry has been to stay ahead in this biological arms race by developing new agents and modifying old ones," Grosso said.

The findings were published online May 29 in the journal Proceedings of the National Academy of Sciences.

More information

The U.S. Food and Drug Administration has more on antibiotic-resistance.